Aps Lab Instruments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 99.66%
- Profit Growth 193.02%
- Ebitda 222.92%
- Net Worth 164.18%
- Total Assets 26.33%
About Aps Lab Instruments
Aps Lab Instruments Private Limited (ALIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 November 2013 and has a history of 11 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aprajita Mall and Pramod Mall serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36912DL2013PTC260730
-
Company No.
260730
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Nov 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Aps Lab Instruments Private Limited offer?
Aps Lab Instruments Private Limited offers a wide range of products and services, including Hospital & Medical Lights, Surgical Light, Warehouses and Warehousing Agents, Freezers, Industrial Air Conditioner & Devices, Cold Rooms, Laboratory & Lab Equipment, Laboratory Cabinets, Hospital and Medical Furniture, Hospital Bed and Mattress.
Who are the key members and board of directors at Aps Lab Instruments?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aprajita Mall
|
Director | 23-Nov-2013 | Current |
|
Pramod Mall
|
Director | 23-Nov-2013 | Current |
Financial Performance of Aps Lab Instruments.
Aps Lab Instruments Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 99.66% increase. The company also saw a substantial improvement in profitability, with a 193.02% increase in profit. The company's net worth Soared by an impressive increase of 164.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aps Lab Instruments?
In 2023, Aps Lab Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aps Lab Instruments?
Unlock and access historical data on people associated with Aps Lab Instruments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aps Lab Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aps Lab Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.